MeiraGTx Holdings (MGTX) Research & Development (2017 - 2025)
MeiraGTx Holdings posted quarterly Research & Development of $30.8 million for Q4 2025, up 28.46% year-on-year from $24.0 million in Q4 2024, and down 5.29% on a QoQ basis from $32.5 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 9 years of Research & Development data on file, last reported at $30.8 million in Q4 2025.
- For the quarter ending Q4 2025, Research & Development rose 28.46% year-over-year to $30.8 million; the trailing twelve-month figure through Dec 2025 stood at $129.6 million (up 8.48% YoY), and the FY2025 full-year result was $129.6 million, up 8.48% from the prior year.
- Research & Development for Q4 2025 stood at $30.8 million, down from $32.5 million in the prior quarter.
- Across five years, Research & Development topped out at $34.9 million in Q2 2024 and bottomed at $13.2 million in Q4 2021.
- The 5-year median for Research & Development is $24.0 million (2022), against an average of $25.3 million.
- The widest annual swing landed in 2021, when Research & Development surged 367.21%; it then decreased 28.76% in 2024.
- A 5-year view of Research & Development shows it stood at $13.2 million in 2021, then surged by 65.11% to $21.8 million in 2022, then surged by 54.7% to $33.7 million in 2023, then fell by 28.76% to $24.0 million in 2024, then grew by 28.46% to $30.8 million in 2025.
- The last three Research & Development figures came in at $30.8 million (Q4 2025), $32.5 million (Q3 2025), and $33.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 364.87 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 30.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.81 Mn |
| Sep 30, 2025 | 32.53 Mn |
| Jun 30, 2025 | 33.50 Mn |
| Mar 31, 2025 | 32.78 Mn |
| Dec 31, 2024 | 23.99 Mn |
| Sep 30, 2024 | 26.24 Mn |
| Jun 30, 2024 | 34.93 Mn |
| Mar 31, 2024 | 34.32 Mn |
| Dec 31, 2023 | 33.67 Mn |
| Sep 30, 2023 | 27.86 Mn |
| Jun 30, 2023 | 19.94 Mn |
| Mar 31, 2023 | 22.32 Mn |
| Dec 31, 2022 | 21.77 Mn |
| Sep 30, 2022 | 16.86 Mn |
| Jun 30, 2022 | 24.00 Mn |
| Mar 31, 2022 | 23.10 Mn |
| Dec 31, 2021 | 13.18 Mn |
| Sep 30, 2021 | 21.61 Mn |
| Jun 30, 2021 | 15.19 Mn |
| Mar 31, 2021 | 16.71 Mn |
| Dec 31, 2020 | 5.00 Mn |
| Sep 30, 2020 | 4.63 Mn |
| Jun 30, 2020 | 16.20 Mn |
| Mar 31, 2020 | 8.08 Mn |
| Dec 31, 2019 | -2.49 Mn |
| Sep 30, 2019 | 4.61 Mn |
| Jun 30, 2019 | 9.77 Mn |
| Mar 31, 2019 | 12.98 Mn |
| Dec 31, 2018 | 10.79 Mn |
| Sep 30, 2018 | 8.11 Mn |
| Jun 30, 2018 | 7.79 Mn |
| Mar 31, 2018 | 6.93 Mn |
| Dec 31, 2017 | 5.78 Mn |
| Sep 30, 2017 | 6.39 Mn |
| Jun 30, 2017 | 5.36 Mn |